Results
1 -
10 of
40Di Fabio Romano, Alvaro Giuseppe, Braggio Simone, Carletti Renzo, Gerrard Philip A., Griffante Cristiana, Marchioro Carla, Pozzan Alfonso, Melotto Sergio, Poffe Alessandro, Piccoli Laura, Ratti Emiliangelo, Tranquillini Elvira, Trower Michael, Spada Simone, Corsi Mauro.
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate, Bioorganic & Medicinal Chemistry, 2013 Chemotherapy-Induced Nausea and Vomiting: Molecular Mechanisms and Clinical Approaches, International Manual of Oncology Practice Treatment of Chemotherapy-Induced Nausea, Management of Chemotherapy-Induced Nausea and Vomiting Management of Chemotherapy-Induced Nausea and Vomiting, Drugs Conclusions, Management of Chemotherapy-Induced Nausea and Vomiting Getting it right the first time: recent progress in optimizing antiemetic usage, Supportive Care in Cancer Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials, Supportive Care in Cancer Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists, Supportive Care in Cancer 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy, Supportive Care in Cancer State of the Art Antiemetic Therapy for Cancer Patients, Current Oncology Reports